Clinical Study
Economic Impact of Infected Total Knee Arthroplasty
Table 3
Cost analysis of infected TKA and the case control group with reimbursements from the G-DRGs in Euro (€).
| Group | Number of patients | Mean cost per patient | Mean reimbursement (G-DRGs) | Mean profit/loss | Cost coverage |
| Infected TKA | 28 | 25,194€ | 18,838€ | −6,356€ | 74.77% | Case control group | 21 | 6,889€ | 7,816€ | +927€ | 111.86% |
|
|